LUMINOPIA, INC.

Profile

Company Names

LUMINOPIA, INC.

Addresses

625 MASSACHUSETTS AVENUE, FLOOR 2, CAMBRIDGE, MA 02139

625 MASSACHUSETTS AVENUE, CAMBRIDGE, MA 02139

222 THIRD STREET, #4000, CAMBRIDGE, MA 02142

245 THUNDERBOWL LANE, ASPEN, CO 81611

Phone Numbers

857-365-6636
970-331-2166

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE, OTHER

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$36,532,482.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2023-06-16 
$15,811,759.00 
$16,811,759.00 
$1,000,000.00 
Equity 
6
2022-10-05 
$4,074,997.00 
$5,134,997.00 
$1,060,000.00 
Equity 
5
2019-11-29 
$11,110,726.00 
$13,611,012.00 
$2,500,286.00 
Equity 
4
2017-09-13 
$1,250,000.00 
$2,050,000.00 
$800,000.00 
Equity, Debt 
3
2017-06-05 
$3,625,000.00 
$5,125,000.00 
$1,500,000.00 
Equity, Debt 
2
2016-10-03 
$410,000.00 
$700,000.00 
$290,000.00 
Equity, Debt 
1
2016-07-05 
$250,000.00 
$500,000.00 
$250,000.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARK 
 
DOCKSER 
EXECUTIVE OFFICER
JEFFREY 
 
DUNN 
DIRECTOR
SI-BONE INC.   |  AQR ABSOLUTE RETURN OFFSHORE FUND LTD   |  CNH CA INSTITUTIONAL FUND, L.P.   |  AQR GLOBAL STOCK SELECTION OFFSHORE FUND (USD) LTD.   |  AQR OFFSHORE MULTI-STRATEGY FUND V LTD.   |  AQR GLOBAL ASSET ALLOCATION OFFSHORE FUND (USD) IV LTD.   |  AQR DELTA OFFSHORE FUND, L.P.   |  AQR DELTA SAPPHIRE FUND, L.P.   |  AQR MULTI-STRATEGY FUND V, L.P.   |  BROAD SCOPE OFFSHORE MULTI-STRATEGY FUND, L.P.   |  AQR INTERNATIONAL EQUITY FUND II, L.P.   |  AQR US DEFENSIVE EQUITY FUND, L.P.   |  AQR REAL ASSET FUND II, L.P.   |  AQR DELTA FUND III, L.P.   |  AQR EQUITY PLUS FUND, L.P.   |  AQR ABSOLUTE RETURN INSTITUTIONAL FUND LP   |  AQR GLOBAL ASSET ALLOCATION INSTITUTIONAL FUND II L P   |  AQR GLOBAL STOCK SELECTION INSTITUTIONAL FUND L P   |  AQR ABSOLUTE RETURN OFFSHORE FUND USD III LTD   |  AQR GLOBAL RISK PREMIUM FUND L P   |  AQR OFFSHORE MULTI-STRATEGY FUND LTD   |  AQR GLOBAL STOCK SELECTION OFFSHORE FUND USD III LTD   |  AQR GLOBAL ASSET ALLOCATION OFFSHORE FUND USD II LTD   |  AQR GLOBAL ASSET ALLOCATION OFFSHORE FUND (USD) LTD   |  AQR GAA GLOBAL TOTAL RETURN FUND LP   |  AQR GLOBAL ASSET ALLOCATION INSTITUTIONAL FUND IV LP   |  AQR GAA ALPHAPORT 500 FUND II LP   |  AQR GLOBAL RISK PREMIUM OFFSHORE FUND LTD   |  AQR GLOBAL RISK PREMIUM OFFSHORE FUND II LTD   |  AQR GLOBAL RISK PREMIUM TACTICAL OFFSHORE FUND LTD   |  AQR GLOBAL STOCK SELECTION HV OFFSHORE FUND LTD   |  AQR SMALL CAP CORE FUND LP   |  AQR RC SMALL CAP CORE FUND LP   |  AQR GLOBAL RISK PREMIUM TACTICAL OFFSHORE FUND II LTD   |  AQR OFFSHORE MULTI-STRATEGY FUND IV LTD.   |  AQR EXTENDED GTAA OFFSHORE FUND LTD.   |  AQR GLOBAL RISK PREMIUM OFFSHORE FUND III LTD.   |  AQR GLOBAL STOCK SELECTION INSTITUTIONAL FUND II, L.P.   |  AQR INTERNATIONAL SMALL CAP EQUITY FUND, L.P.   |  AQR LIQUIDITY FUND, L.P.   |  AQR SMALL CAP VALUE FUND, L.P.   |  AQR EMERGING EQUITIES FUND LP   |  AQR DELTA TOTAL RETURN FUND LP   |  ALPHABLEND GLOBAL EQUITY FUND I LP   |  AQR RT FUND, L.P.   |  AQR DELTA OFFSHORE FUND II LTD.   |  AQR REAL RETURN FUND, L.P.   |  AK OVERLAY PORTFOLIO, L.P.   |  AQR GLOBAL RISK PREMIUM OFFSHORE FUND (GBP) LTD.   |  AQR DELTA OFFSHORE FUND IV, L.P.   |  AQR REAL RETURN OFFSHORE FUND, L.P.   |  AQR GRP 10 OFFSHORE FUND LTD.   |  AQR GRP EL FUND, LP   |  AQR GRP EL 12 OFFSHORE FUND LTD.   |  AQR DIVERSIFIED FUTURES FUND, L.P.   |  AQR MANAGED FUTURES FUND, L.P.   |  AQR GLOBAL RISK PREMIUM FUND III, L.P.   |  SCM SPECIALTY FINANCE OPPORTUNITIES FUND, L.P.   |  AQR QUANTITATIVE FUTURES FUND, L.P.   |  AQR DELTA OFFSHORE FUND V LTD.   |  AQR GLOBAL STOCK SELECTION HV MASTER ACCOUNT LTD.   |  AQR ORACLE FUND, L.P.   |  AQR JONES CREEK SMALL CAP VALUE FUND, L.P.   |  AQR GIBRALTAR FUND, L.P.   |  AQR MANAGED FUTURES OFFSHORE FUND LTD.   |  AQR DELTA OFFSHORE FUND (GBP) LTD.   |  AQR DIVERSIFIED CONVEXITY FUND, L.P.   |  AQR CHURCHILL FUND, L.P.   |  AQR ARF GLOBAL TOTAL RETURN FUND II, L.P.   |  AQR CUSTOMIZED REAL RETURN OFFSHORE FUND, L.P.   |  AQR ALL COUNTRY INTERNATIONAL EQUITY FUND, L.P.   |  AQR GLOBAL RISK PREMIUM FUND II, L.P.   |  AQR STYLE PREMIA FUND, L.P.   |  AQR GLOBAL DEFENSIVE EQUITY FUND, L.P.   |  AQR GLOBAL MACRO FUND, L.P.   |  AQR GRP EL OFFSHORE FUND LTD.   |  AQR GRP EL 20 OFFSHORE FUND LTD.   |  AQR OPPORTUNISTIC PREMIUM OFFSHORE FUND, L.P.   |  AQR DELTA FUND II, L.P.   |  AQR OFFSHORE MULTI-STRATEGY FUND VII LTD.   |  AQR EMERGING DEFENSIVE EQUITY OFFSHORE FUND LTD.   |  AQR OFFSHORE MULTI-STRATEGY FUND (AUD) LTD.   |  AQR OFFSHORE MULTI-STRATEGY FUND VI LTD.   |  AQR MRP OFFSHORE FUND, L.P.   |  AQR MULTI-ASSET CLASS FUND, L.P.   |  AQR STYLE PREMIA OFFSHORE FUND LTD.   |  SI-BONE, INC.   |  AQR DELTA XN FUND, L.P.   |  AQR CHURCHILL MASTER ACCOUNT, L.P.   |  AQR DELTA XN OFFSHORE FUND, L.P.   |  AQR OFFSHORE MULTI-STRATEGY FUND IX LTD.   |  AQR OPTIONS ENHANCED U.S. EQUITY MASTER ACCOUNT, L.P.   |  AQR GRP EL 15 OFFSHORE FUND LTD.   |  AQR TAX PLUS U.S. HEDGED EQUITY FUND, L.P.   |  AQR STYLE PREMIA OFFSHORE FUND II, L.P.   |  AQR STYLE PREMIA ALPHAPORT FUND, L.P.   |  LUMINOPIA, INC.   |  REILEY PHARMACEUTICALS, INC.   |  REDIVUS HEALTH, INC.
JOI 
 
ITO 
DIRECTOR
MARK 
 
JACOBSTEIN 
DIRECTOR
ROBERT 
 
LANGER 
DIRECTOR
MICROCHIPS, INC.   |  ARSENAL MEDICAL, INC.   |  ALSERES PHARMACEUTICALS INC /DE   |  ECHO THERAPEUTICS, INC.   |  MICELL TECHNOLOGIES INC   |  CERULEAN PHARMA INC.   |  HUMACYTE INC   |  COMBINENT BIOMEDICAL SYSTEMS, INC.   |  TARIS BIOMEDICAL INC   |  KALA PHARMACEUTICALS, INC.   |  FIBROCELL SCIENCE, INC.   |  PREDICTIVE BIOSCIENCES, INC   |  SEVENTH SENSE BIOSYSTEMS, INC.   |  T2 BIOSYSTEMS, INC.   |  SEMPRUS BIOSCIENCES CORP   |  LIQUIDX, INC.   |  ARSENAL VASCULAR, INC.   |  ARSENAL MEDICAL, INC.   |  SELECTA BIOSCIENCES INC   |  STEMNION, INC.   |  480 BIOMEDICAL, INC.   |  LIVING PROOF INC   |  DX BIOSCIENCES, INC.   |  MODERNA LLC   |  HUMACYTE, INC   |  XTUIT PHARMACEUTICALS, INC.   |  SQZ BIOTECHNOLOGIES CO   |  NOVEOME BIOTHERAPEUTICS, INC.   |  LYNDRA, INC.   |  MODERNA THERAPEUTICS, INC.   |  VERSEAU THERAPEUTICS, INC.   |  FREQUENCY THERAPEUTICS, INC.   |  SUONO BIO, INC.   |  COMBINED THERAPEUTICS, INC.   |  HUMACYTE, INC.   |  SEER BIOSCIENCES, INC.   |  LANDSDOWNE LABS, LLC   |  LIKEMINDS, INC./DE   |  TARVEDA THERAPEUTICS, INC.   |  LUMINOPIA, INC.   |  LYRA THERAPEUTICS, INC.   |  ABPRO CORP   |  GLYMPSE BIO, INC.   |  EPIBONE, INC.   |  TEAL BIO, INC.   |  ZWI THERAPEUTICS, INC.   |  LYNDRA THERAPEUTICS, INC.   |  KENDALL CAPITAL PARTNERS I, L.P.   |  BILAYER THERAPEUTICS, INC.   |  XENTER, INC.   |  VIVTEX CORP   |  SYNTIS BIO, INC.   |  OMNIPULSE BIOSCIENCES, INC.
MICHELLE 
 
LEE 
DIRECTOR
DEAN 
 
TRAVERS 
DIRECTOR, EXECUTIVE OFFICER, PROMOTER
DEAN 
A. 
TRAVERS 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ALEXANDER 
 
WENDLAND 
EXECUTIVE OFFICER, DIRECTOR
SCOTT 
 
XIAO 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-16 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-05 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-29 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2017-06-05 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2017-09-13 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-10-03 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-07-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#